For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Chemosensitivity Testing | Leukemia cells purified from blood or bone marrow samples are analyzed for sensitivity to individual drugs and drug combination and by next generation sequencing. Chemosensitivity Assay: Lab test in which leukemia cells obtained from blood or bone marrow are tested for sensitivity to 115 drugs individually and in certain combinations Cytology Specimen Collection Procedure: Undergo blood or bone marrow collection Gene Expression Analysis: Analysis of leukemia cell genes to identify possible drug targets Genetic Variation Analysis: Analysis of leukemia cell genes to identify possible drug targets In Vitro Sensitivity-Directed Chemotherapy: Receive personalized chemotherapy with one or more of the following drugs: Afatinib Arsenic trioxide Axitinib Azacitidine Bexarotene Bortezomib Bosutinib Busulfan Cabazitaxel Cabozantinib Carfilzomib Ceritinib Cladribine Clofarabine Crizotinib Cytarabine HCl Dabrafenib Dasatinib Daunorubicin HCl Decitabine Erlotinib Etoposide Everolimus Fludarabine Gefitinib Gemcitabine HCl Hydroxyurea Imatinib Irinotecan Lapatinib Lomustine Melphalan Mercaptopurine Methotrexate Mitoxantrone Nelarabine Nilotinib Paclitaxel Pazopanib Pentostatin Ponatinib Pralatrexate Rapamycin Regorafenib Romidepsin Ruxolitinib Sorafenib Sunitinib Temsirolimus Thioguanine Topotecan HCl Trametinib Tretinoin | 32 | None | 11 | 34 | 26 | 34 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Intermittent Thrombocytopenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pulmonary Edema | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Respiratory Distress | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Rhizopus Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Septic Shock | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Tumor Lysis Syndrome | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Leukocytosis | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Neutropenic fever with Sepsis Physiology | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Anaphylaxis | NON_SYSTEMATIC_ASSESSMENT | Immune system disorders | None | View |
| Dyspnea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Enterobacter Cloacae Sepsis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Hypotension | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypoxemic Respiratory Failure | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Atrial Fibrillation with RVR | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Acute Kidney Injury | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Alanine Aminotransferase Increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Anorectal Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Anorexia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Aspartate Aminotransferase Increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Bacteremia Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| C. Diff Colitis with Diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Catheter Related Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Central Line Associated DVT | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Coag Negative Staph Bacteremia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Distributive Shock | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Enterocolitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Eye Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Fall | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Febrile Neutropenia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Granulicatella Adiacens Bacteremia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Heart Failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Hyperbilirubinemia | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Hyperglycemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Hypertension | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypotension | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Hypoxia | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| INR Increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Invasive Fungal Sinusitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Lung Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Oral Mucositis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pleural Effusion | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pseudomonas Bacteremia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Pulmonary Edema | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Rash Maculopapular | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rothia Mucilaginosa Bacteremia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Sepsis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Staph Epidermidis Bacteremia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Staphylococcus Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Stenotrophomonas Maltophilia Bacteremia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Subdural Hematoma | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Syncope | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Transaminitis | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Tumor Lysis Syndrome | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Urinary Tract Infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |